Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Hold from Kepler Capital

Tipranks - Tipranks - Thu Mar 12, 8:50PM CDT

Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA on March 10 and set a price target of €43.00. The company’s shares closed last Tuesday at €39.59.

Claim 70% Off TipRanks Premium

According to TipRanks, Reinberg is an analyst with an average return of -5.7% and a 40.96% success rate. Reinberg covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care AG & Co. KGaA, STRATEC Biomedical, and Draegerwerk AG & Co. KGaA.

In addition to Kepler Capital , Fresenius Medical Care AG & Co. KGaA also received a Hold from Deutsche Bank ‘s Falko Friedrichs in a report issued on March 2. However, on March 10, UBS maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

See today’s best-performing stocks on TipRanks >>

Based on Fresenius Medical Care AG & Co. KGaA’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of €5.07 billion and a net profit of €327 million. In comparison, last year the company earned a revenue of €5.08 billion and had a net profit of €66.91 million

Read More on GB:0H9X:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).